202 related articles for article (PubMed ID: 14719804)
21. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and
Corrigan TS; Lotti Diaz LM; Border SE; Ratigan SC; Kasper KQ; Sojka D; Fajtova P; Caffrey CR; Salvesen GS; McElroy CA; Hadad CM; Doğan Ekici Ö
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1387-1402. PubMed ID: 32633155
[TBL] [Abstract][Full Text] [Related]
24. Cysteine proteinases from Schistosoma haematobium adult worms.
Rege AA; Wang W; Dresden MH
J Parasitol; 1992 Feb; 78(1):16-23. PubMed ID: 1371156
[TBL] [Abstract][Full Text] [Related]
25. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
26. The importance of the active site histidine for the activity of epoxide- or aziridine-based inhibitors of cysteine proteases.
Mladenovic M; Schirmeister T; Thiel S; Thiel W; Engels B
ChemMedChem; 2007 Jan; 2(1):120-8. PubMed ID: 17066390
[TBL] [Abstract][Full Text] [Related]
27. Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries.
Mathieu MA; Bogyo M; Caffrey CR; Choe Y; Lee J; Chapman H; Sajid M; Craik CS; McKerrow JH
Mol Biochem Parasitol; 2002 Apr; 121(1):99-105. PubMed ID: 11985866
[TBL] [Abstract][Full Text] [Related]
28. Asparaginyl endopeptidase activity in adult Schistosoma mansoni.
Dalton JP; Hola-Jamriska L; Brindley PJ
Parasitology; 1995 Dec; 111 ( Pt 5)():575-80. PubMed ID: 8559590
[TBL] [Abstract][Full Text] [Related]
29. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
[TBL] [Abstract][Full Text] [Related]
30. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase.
Chen JM; Dando PM; Rawlings ND; Brown MA; Young NE; Stevens RA; Hewitt E; Watts C; Barrett AJ
J Biol Chem; 1997 Mar; 272(12):8090-8. PubMed ID: 9065484
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cysteine peptidase activities in Trichobilharzia regenti and Schistosoma mansoni cercariae.
Kasný M; Mikes L; Dalton JP; Mountford AP; Horák P
Parasitology; 2007 Oct; 134(Pt 11):1599-609. PubMed ID: 17517170
[TBL] [Abstract][Full Text] [Related]
32. Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead.
Ettari R; Tamborini L; Angelo IC; Grasso S; Schirmeister T; Lo Presti L; De Micheli C; Pinto A; Conti P
ChemMedChem; 2013 Dec; 8(12):2070-6. PubMed ID: 24243827
[TBL] [Abstract][Full Text] [Related]
33. Pig kidney legumain: an asparaginyl endopeptidase with restricted specificity.
Dando PM; Fortunato M; Smith L; Knight CG; McKendrick JE; Barrett AJ
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):743-9. PubMed ID: 10215615
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
Lee J; Bogyo M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
[TBL] [Abstract][Full Text] [Related]
35. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
36. Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the stereoselectivity of epoxide-based inhibitors.
Mladenovic M; Ansorg K; Fink RF; Thiel W; Schirmeister T; Engels B
J Phys Chem B; 2008 Sep; 112(37):11798-808. PubMed ID: 18712902
[TBL] [Abstract][Full Text] [Related]
37. Differential inhibitory effect of newly synthesized pyridine-2-one derivatives on the cercarial serine protease activity of the parasite Schistosoma mansoni.
Bahgat M; Khalifa N
Acta Pol Pharm; 2006; 63(3):181-8. PubMed ID: 20085222
[TBL] [Abstract][Full Text] [Related]
38. Activity-based probes that target diverse cysteine protease families.
Kato D; Boatright KM; Berger AB; Nazif T; Blum G; Ryan C; Chehade KA; Salvesen GS; Bogyo M
Nat Chem Biol; 2005 Jun; 1(1):33-8. PubMed ID: 16407991
[TBL] [Abstract][Full Text] [Related]
39. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
Löser R; Frizler M; Schilling K; Gütschow M
Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
[No Abstract] [Full Text] [Related]
40. Expression and partial characterization of a cathepsin B-like enzyme (Sm31) and a proposed 'haemoglobinase' (Sm32) from Schistosoma mansoni.
Götz B; Klinkert MQ
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):801-6. PubMed ID: 8457210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
